Dana-Farber
In Brief This Week: Foundation Medicine, Myriad Genetics, Immunovia, Biocept, and More
News items for the in vitro diagnostics industry for the week of June 28, 2021.
In Brief This Week: Quest Diagnostics, Biodexis, Caris Life Sciences, SkylineDx, and More
News items for the in vitro diagnostics industry for the week of Feb. 15, 2021.
Esophageal Cancer Case Study Suggests Utility as Clinicians Explore Expanded Uses for Liquid Biopsy
Investigators reported on how ctDNA, measured using Natera's patient-specific Signatera assays, corresponded to a patient's disease progression and other biomarkers.
Grail Multi-Cancer Test Meets Validation Goals; Patients to Receive Results Under New Pilot
Researchers published the most comprehensive data to date showing that Grail's screening approach can detect and distinguish a significant number of cancers.
Dana Faber Cancer Institute, AroCell Evaluating Use of ELISA to Detect Cancer Marker
They are seeking to determine the concordance between thymidine kinase 1 enzyme concentration in serum and patients' clinical response to treatment.
Jul 6, 2018
Nov 9, 2017